UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 556

Sortiert nach

Drugging the 'undruggable' cancer targets

Nature reviews. Cancer, 2017-08, Vol.17 (8), p.502

2017

Link zum Volltext

Verfügbarkeit prüfen

Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design

Nature reviews. Drug discovery, 2016-11, Vol.15 (11), p.771-785

2016

Link zum Volltext

Verfügbarkeit prüfen

Drugging MYCN through an Allosteric Transition in Aurora Kinase A

Cancer cell, 2014-09, Vol.26 (3), p.414-427

2014

Link zum Volltext

Verfügbarkeit prüfen

Bifunctional Small‐Molecule Ligands of K‐Ras Induce Its Association with Immunophilin Proteins

Angewandte Chemie (International ed.), 2019-11, Vol.58 (45), p.16314-16319

International ed. in English, 2019

Link zum Volltext

Verfügbarkeit prüfen

The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling

Annual review of biochemistry, 2011-07, Vol.80 (1), p.769-795

2011

Link zum Volltext

Verfügbarkeit prüfen

A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1

Cell, 2013-08, Vol.154 (4), p.737-747

2013

Link zum Volltext

Verfügbarkeit prüfen

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

Nature (London), 2013-11, Vol.503 (7477), p.548-551

2013

Link zum Volltext

Verfügbarkeit prüfen

Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP

Cell, 2018-05, Vol.173 (5), p.1254-1264.e11

2018

Link zum Volltext

Verfügbarkeit prüfen

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2

PLoS biology, 2009-02, Vol.7 (2), p.e38-e1000038

2009

Link zum Volltext

Verfügbarkeit prüfen

Targeting the cancer kinome through polypharmacology

Nature reviews. Cancer, 2010-02, Vol.10 (2), p.130

2010

Link zum Volltext

Verfügbarkeit prüfen

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

Nature (London), 2010-03, Vol.464 (7287), p.427-430

2010

Link zum Volltext

Verfügbarkeit prüfen

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

Science (American Association for the Advancement of Science), 2021-02, Vol.371 (6532), p.926-931

2021

Link zum Volltext

Verfügbarkeit prüfen

EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma

Cancer cell, 2013-10, Vol.24 (4), p.438-449

2013

Link zum Volltext

Verfügbarkeit prüfen

Chemical genetic discovery of targets and anti-targets for cancer polypharmacology

Nature (London), 2012-06, Vol.486 (7401), p.80-84

2012

Link zum Volltext

Verfügbarkeit prüfen

Chemical Genetic Screen for AMPKα2 Substrates Uncovers a Network of Proteins Involved in Mitosis

Molecular cell, 2011-12, Vol.44 (6), p.878-892

2011

Link zum Volltext

Verfügbarkeit prüfen

Evolutionarily divergent mTOR remodels translatome for tissue regeneration

Nature (London), 2023-08, Vol.620 (7972), p.163-171

2023

Link zum Volltext

Verfügbarkeit prüfen

Drugging the Next Undruggable KRAS Allele-Gly12Asp

Journal of medicinal chemistry, 2022-02, Vol.65 (4), p.3119-3122

2022

Link zum Volltext

Verfügbarkeit prüfen

A Cdk7-Cdk4 T-Loop Phosphorylation Cascade Promotes G1 Progression

Molecular cell, 2013-04, Vol.50 (2), p.250-260

2013

Link zum Volltext

Verfügbarkeit prüfen

A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability

Cancer discovery, 2023-01, Vol.13 (1), p.56-69

2023

Link zum Volltext

Verfügbarkeit prüfen

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Science (American Association for the Advancement of Science), 2021-07, Vol.373 (6554), p.541-547

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification of AMPK Phosphorylation Sites Reveals a Network of Proteins Involved in Cell Invasion and Facilitates Large-Scale Substrate Prediction

Cell metabolism, 2015-11, Vol.22 (5), p.907-921

2015

Link zum Volltext

Verfügbarkeit prüfen

Chemoselective Covalent Modification of K‑Ras(G12R) with a Small Molecule Electrophile

Journal of the American Chemical Society, 2022-09, Vol.144 (35), p.15916-15921

2022

Link zum Volltext

Verfügbarkeit prüfen

Brain-restricted mTOR inhibition with binary pharmacology

Nature (London), 2022-09, Vol.609 (7928), p.822-828

2022

Link zum Volltext

Verfügbarkeit prüfen

Site-specific incorporation of phosphotyrosine using an expanded genetic code

Nature chemical biology, 2017-08, Vol.13 (8), p.842

2017

Link zum Volltext

Verfügbarkeit prüfen

MST3 kinase phosphorylates TAO1/2 to enable Myosin Va function in promoting spine synapse development

Neuron (Cambridge, Mass.), 2014-12, Vol.84 (5), p.968-982

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 556

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(509)
Mit Volltextzugriff
(491)

Publikationsform

Artikel
(535)
Buchkapitel
(18)
Bücher
(3)

Sprache

Englisch
(553)
Japanisch
(147)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(368)
Life Sciences & Biomedicine
(282)
Humans
(196)
Animals
(172)
Biochemistry & Molecular Biology
(153)
Cell Biology
(120)
Mice
(116)
Phosphorylation
(105)
Kinases
(83)
Mutation
(82)
Proteins
(78)
Multidisciplinary Sciences
(64)
Science & Technology - Other Topics
(64)
Signal Transduction
(62)
Cell Line, Tumor
(54)
Molecular Biology
(54)
Substrate Specificity
(52)
Biochemistry
(51)
Models, Molecular
(48)
Protein Kinase Inhibitors - Pharmacology
(48)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Proceedings Of The National Academy Of Sciences - Pnas
(37)
Cancer Research
(35)
The Journal Of Biological Chemistry
(30)
Nature
(20)
Chemistry & Biology
(17)
Proceedings Of The National Academy Of Sciences
(16)
Molecular Cell
(15)
Cell
(13)
Science
(13)
Angewandte Chemie
(12)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Drugging the 'undruggable' cancer targets

Direct small-molecule inhibitors of KRAS: from structural insights to mechanism-based design

Drugging MYCN through an Allosteric Transition in Aurora Kinase A

Bifunctional Small‐Molecule Ligands of K‐Ras Induce Its Association with Immunophilin Proteins

The Evolution of Protein Kinase Inhibitors from Antagonists to Agonists of Cellular Signaling

A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

Disease-Causing Mutations in the G Protein Gαs Subvert the Roles of GDP and GTP

Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2

Targeting the cancer kinome through polypharmacology

RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A

EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma

Chemical genetic discovery of targets and anti-targets for cancer polypharmacology

Chemical Genetic Screen for AMPKα2 Substrates Uncovers a Network of Proteins Involved in Mitosis

Evolutionarily divergent mTOR remodels translatome for tissue regeneration

Drugging the Next Undruggable KRAS Allele-Gly12Asp

A Cdk7-Cdk4 T-Loop Phosphorylation Cascade Promotes G1 Progression

A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Identification of AMPK Phosphorylation Sites Reveals a Network of Proteins Involved in Cell Invasion and Facilitates Large-Scale Substrate Prediction

Chemoselective Covalent Modification of K‑Ras(G12R) with a Small Molecule Electrophile

Brain-restricted mTOR inhibition with binary pharmacology

Site-specific incorporation of phosphotyrosine using an expanded genetic code

MST3 kinase phosphorylates TAO1/2 to enable Myosin Va function in promoting spine synapse development

Suchergebnisse filtern